Conferences \ Current Trends in Antibody Drug Conjugates \ Agenda \ Palani Palaniappan |
Register | Login |
Safety & Efficacy of Antibody Drug Conjugates- Where are We Currently?Tuesday, 3 March 2015 at 16:30 Add to Calendar ▼2015-03-02 12:05:002015-03-02 13:05:00Europe/LondonComparability during Preclinical and Clinical Development ContinuumCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com Ajay
Kumar Gupta, Senior Counsellor / Director & Head, Confederation of
Indian Industry, India Jeremy
Parker, Principal Scientist, AstraZeneca, United Kingdom Mark
Wright, Site Lead, Piramal Healthcare UK Ltd, United Kingdom Comparability during Preclinical and Clinical Development ContinuumMonday, 2 March 2015 at 12:05 Add to Calendar ▼2015-03-02 12:05:002015-03-02 13:05:00Europe/LondonComparability during Preclinical and Clinical Development ContinuumCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore, IndiaSELECTBIOenquiries@selectbiosciences.com The presentation will describe some general approaches for biological, analytical and preclinical approaches for establishing comparability of materials through development continuum. |